MedPath

Safety and efficacy of assessment of Alis collagen drink (containing 4 g hydrolyzed collagen) compared to a control collagen-free drink

Phase 2
Conditions
skin aging.
Registration Number
IRCT20150101020514N22
Lead Sponsor
Pishgamane Eixire Sabze Arvand Co.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Ages 35 to 55
Healthy people with skin type II to V
Signing the consent form for participation in the study

Exclusion Criteria

History of using RF, anti aging and intense pulsed light during the past 6 months
.Active smoker in last 2 years
Pregnancy or lactating
Suffering from systemic diseases that affect skin health, such as vascular collagen diseases, diabetes, hypothyroidism, as well as liver and kidney failure.
History of taking supplements containing collagen, hyaluronic acid and vitamin C in the last 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Skin elasticity. Timepoint: Before intervention , 4, 8 and 12 weeks after using. Method of measurement: Cutometery.
Secondary Outcome Measures
NameTimeMethod
Skin thickness and density. Timepoint: Before intervention ,4 , 8 and 12 weeks after using. Method of measurement: Skin ultrasound.;Changes in stratum corneum hydration. Timepoint: Before intervention , 4, 8 and 12 weeks after using. Method of measurement: Corneometry.
© Copyright 2025. All Rights Reserved by MedPath